Clinical trial
A Clinical Study of CD19 Chimeric Antigen Receptor T-Cell Therapy for Patients With Refractory Childhood-Onset Systemic Lupus Erythematosus
NCT07855302 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Study of CD19 Chimeric Antigen Receptor T-Cell Therapy for Patients With Refractory Childhood-Onset Systemic Lupus Erythematosus
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- September 14, 2026
- Completion date
- December 31, 2028
- Enrollment
- 8 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cd19 car-t cell therapy, childhood-onset systemic lupus erythematosus, refractory sle